Elevated levels of MMP-9 are frequently observed in a range of fibrotic conditions, including Idiopathic Pulmonary Fibrosis (IPF) and Systemic Sclerosis (SSc) [115,116,117]
Hao RT, Zheng C, Wu CY, Xia EJ, Zhou XF, Quan RD, et al
This innovative treatment has shown promising results in addressing weight management, making it a potential game-changer in the field of obesity and metabolic health
Marlene, who asked that her face be blurred and her middle name used to protect her identity, started taking a GLP-1 drug in August 2025
And because these drugs are relatively new to the market, more research is needed to further understand long-term effects on other health outcomes
That $50 co-pay is more than $1,000 less than the typical, monthly out-of-pocket cost for the GLP-1 brand names that Medicare is covering: Wegovy, Zepbound or Foundayo